Tetanus
Showing 51 - 75 of 204
Diphtheria, Tetanus, Pertussis Trial (DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV)
Unknown status
- Diphtheria
- +5 more
- DTwP-HepB-Sabin IPV-Hib
- Pentavalent vaccine and Salk IPV
- (no location specified)
Sep 3, 2019
Diphtheria, Tetanus, Pertussis Trial in Seoul (DTP-HepB-IPV-Hib vaccine, DTP-HepB-Hib vaccine & IPV)
Completed
- Diphtheria
- +5 more
- DTP-HepB-IPV-Hib vaccine
- DTP-HepB-Hib vaccine & IPV
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Aug 27, 2019
Hepatitis B, Diphtheria, Haemophilus Influenzae Type B Infection Trial (Eupenta Inj.)
Unknown status
- Hepatitis B
- +4 more
- Eupenta Inj.
- (no location specified)
Aug 13, 2019
Acellular Pertussis, Tetanus, Poliomyelitis Trial in Worldwide (Infanrix hexa, Prevnar13)
Completed
- Acellular Pertussis
- +4 more
- Infanrix hexa
- Prevnar13
-
Carlton, Victoria, Australia
- +29 more
Jun 26, 2019
Acellular Pertussis, Diphtheria, Tetanus Trial in United States (Fluarix®, Boostrix®)
Completed
- Acellular Pertussis
- +2 more
- Fluarix®
- Boostrix®
-
Huntsville, Alabama
- +11 more
Jun 6, 2019
Diphtheria, Tetanus, Pertussis Trial in Hung Yen (Study subjects will be vaccinated with 3 (three) vaccine doses. The first
Completed
- Diphtheria
- +4 more
- Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
-
Hung Yen, VietnamHung Yen, Kim Dong
May 1, 2019
Tetanus, Acellular Pertussis, Diphtheria Trial in Korea, Republic of (DTPa-IPV, DTPa, IMOVAX Polio®)
Completed
- Tetanus
- +2 more
- DTPa-IPV
- +2 more
-
Bucheon-si,, Korea, Republic of
- +8 more
Jul 13, 2018
Tetanus, Acellular Pertussis, Diphtheria Trial in United States (GSK Biologicals'Kinrix®, Merck and Company's MMRII, Merck and
Completed
- Tetanus
- +2 more
- GSK Biologicals'Kinrix®
- +2 more
-
Antioch, California
- +10 more
Jul 25, 2018
Tetanus, Hepatitis B, Haemophilus Influenzae Type b Trial in Canada, France, Germany (GSK2202083A vaccine, Prevenar 13®,
Completed
- Tetanus
- +6 more
- GSK2202083A vaccine
- +4 more
-
Vancouver, British Columbia, Canada
- +33 more
Jun 28, 2018
Tetanus, Poliomyelitis, Hepatitis B Trial in Dominican Republic, Finland (Infanrix hexa™, Prevenar 13®, GSK217744)
Completed
- Tetanus
- +5 more
- Infanrix hexa™
- +2 more
-
Santo Domingo, Distrito Nacional, Dominican Republic
- +15 more
Jun 28, 2018
Acellular Pertussis, Tetanus, Diphtheria Trial in Bruxelles, Leuven, Wilrijk (Boostrix™, Boostrix™-US formulation)
Completed
- Acellular Pertussis
- +2 more
- Boostrix™
- Boostrix™-US formulation
-
Bruxelles, Belgium
- +2 more
Jun 28, 2018
Acellular Pertussis, Poliomyelitis, Tetanus Trial in United Kingdom (Boostrix PolioTM, RepevaxTM, PriorixTM)
Completed
- Acellular Pertussis
- +3 more
- Boostrix PolioTM
- +2 more
-
St Austell, Cornwall, United Kingdom
- +12 more
Jul 11, 2018
Acellular Pertussis, Tetanus, Diphtheria Trial in United States (Boostrix®, Menactra™)
Completed
- Acellular Pertussis
- +2 more
- Boostrix®
- Menactra™
-
Chandler, Arizona
- +23 more
Jun 20, 2018
Diphtheria, Hepatitis B, Whole Cell Pertussis Trial in Muntinlupa (Tritanrix-HepB/Meningitec conjugate vaccine,
Completed
- Diphtheria
- +4 more
- Tritanrix-HepB/Meningitec conjugate vaccine
- Tritanrix/Hiberix vaccine
-
Muntinlupa, PhilippinesGSK Investigational Site
Aug 13, 2018
Hepatitis B, Diphtheria, Whole Cell Pertussis Trial in Bangkok (Tritanrix-HepB/Meningitec conjugate vaccine, Tritanrix/Hiberix
Completed
- Hepatitis B
- +4 more
- Tritanrix-HepB/Meningitec conjugate vaccine
- Tritanrix/Hiberix vaccine
-
Bangkok, ThailandGSK Investigational Site
Aug 13, 2018
Diphtheria, Tetanus, Acellular Pertussis Trial in Santiago, Monterrey, Estado de Mexico (Boostrix TM (new syringe presentation),
Completed
- Diphtheria
- +2 more
- Boostrix TM (new syringe presentation)
- Boostrix TM (previous syringe presentation)
-
Santiago, Chile
- +2 more
Jul 31, 2018
Acellular Pertussis, Diphtheria, Tetanus Trial in United States (Boostrix™, ADACEL®)
Completed
- Acellular Pertussis
- +2 more
- Boostrix™
- ADACEL®
-
Huntsville, Alabama
- +41 more
Feb 2, 2018
Diphtheria, Tetanus, Acellular Pertussis Trial in Hanoi (Boostrix™)
Completed
- Diphtheria
- +2 more
- Boostrix™
-
Hanoi, VietnamGSK Investigational Site
Jun 14, 2018
Antitetanus Vaccination for People Older Than 65 Years.
Completed
- Tetanus
- Questionnaire Patients
- Questionnaire General practitioner
-
Bron, FranceService Urgence et Réanimation Pédiatrique Hôpital Femme Mère En
Jun 8, 2018
Tetanus, Diphtheria, Pneumococcal Infections Trial (Tetanus-diphtheria (Td) and PCV13, PCV13 alone, Td alone)
Completed
- Tetanus
- +2 more
- Tetanus-diphtheria (Td) and PCV13
- +2 more
- (no location specified)
May 29, 2018
Haemophilus Influenzae Type b, Acellular Pertussis, Diphtheria Trial in Wuzhou (Infanrix™-IPV/Hib)
Completed
- Haemophilus Influenzae Type b
- +4 more
- Infanrix™-IPV/Hib
-
Wuzhou, Guangxi, ChinaGSK Investigational Site
Apr 27, 2018
Poliomyelitis, Diphtheria, Tetanus Trial in Germany (Boostrix-Polio)
Completed
- Poliomyelitis
- +3 more
- Boostrix-Polio
-
Ettenheim, Baden-Wuerttemberg, Germany
- +37 more
Apr 27, 2018
Tetanus, Poliomyelitis, Acellular Pertussis Trial in Wuzhou (Infanrix-IPV/Hib™, Infanrix Hib™, Poliorix™)
Completed
- Tetanus
- +4 more
- Infanrix-IPV/Hib™
- +2 more
-
Wuzhou, Guangxi, China
- +1 more
Apr 27, 2018
Acellular Pertussis, Diphtheria, Poliomyelitis Trial in Finland (Infanrix Hexa)
Completed
- Acellular Pertussis
- +5 more
- Infanrix Hexa
-
Jarvenpaa, Finland
- +5 more
Apr 27, 2018